Invokana Lawsuit

Invokana is a prescription drug used to treat type-2 diabetes. It is manufactured by Janssen Pharmaceuticals (a division of Johnson & Johnson corporation). A lawsuit was filed in the U.S. District Court for the District of New Jersey alleging the plaintiff suffered a life threating reaction to the drug.

The plaintiff in this case stated in the court filing that she suffered from diabetic ketoacidosis after taking the drug Invokana. She also suffered severe kidney damage. Diabetic ketoacidosis is a serious condition where the body begins to burn fat to energy because cells had not received the glucose needed for energy. Ketones are chemicals that are created when the body burns fat for energy. When ketones begin to build up in the bloodstream, the blood becomes acidic. High levels of ketones can cause diabetic ketoacidosis, where the body is poisoned. Patients can become comatose, suffer kidney damage, and in extreme cases die.

The FDA has issued two major safety warnings about Invokana. The drug was approved by the FDA for use in 2013. The first warning was issued in May 2015 and stated that diabetic ketoacidosis can occur when using the drug. In September 2015 a warning was issued that there is an increased risk of bone fractures and decreased bone density from using the drug.

Other side effects that have been reported include kidney stones, urinary tract infections, and kidney impairment or failure.

Leave a Reply